Edition:
United Kingdom

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

3.57USD
13 Sep 2019
Change (% chg)

$-0.18 (-4.80%)
Prev Close
$3.75
Open
$3.78
Day's High
$3.78
Day's Low
$3.46
Volume
28,964
Avg. Vol
44,628
52-wk High
$7.59
52-wk Low
$2.92

Latest Key Developments (Source: Significant Developments)

Cerecor - FDA Accepts Ind Application For Cerecor’S Investigational Drug Cerc-802 For The Treatment Of Mpi-Cdg
Monday, 29 Jul 2019 

July 29 (Reuters) - Cerecor Inc ::FDA ACCEPTS IND APPLICATION FOR CERECOR’S INVESTIGATIONAL DRUG CERC-802 FOR THE TREATMENT OF MPI-CDG.CERECOR - CONTINUE TO WORK WITH FDA TO ACCELERATE DEVELOPMENT, APPROVAL OF CERC-802 VIA 505(B)(2) PATHWAY WITH TARGETED NDA SUBMISSION OF 2021.  Full Article

Cerecor Says Notified Nasdaq Co No Longer In Compliance With Listing Rule 5605(B)(1)
Friday, 29 Mar 2019 

March 29 (Reuters) - Cerecor Inc ::CERECOR INC SAYS ON MARCH 27, CO NOTIFIED NASDAQ THAT CO WAS NO LONGER IN COMPLIANCE WITH NASDAQ LISTING RULE 5605(B)(1) - SEC FILING.CERECOR - ON MARCH 28, NASDAQ ISSUED LETTER TO CO CONFIRMING NONCOMPLIANCE WITH MAJORITY INDEPENDENCE REQUIREMENTS OF NASDAQ LISTING RULE 5605(B)(1).  Full Article

Cerecor Inc - Files For Offering Of 1.5 Million Shares Of Common Stock At $5.50 Per Share - SEC Filing
Tuesday, 5 Mar 2019 

March 5 (Reuters) - Cerecor Inc ::CERECOR INC - FILES FOR OFFERING OF 1.5 MILLION SHARES OF COMMON STOCK AT $5.50 PER SHARE - SEC FILING.  Full Article

Cerecor Inc Files For Secondary Offering Of Up To 18.3 Mln Shares Of Common Stock
Thursday, 17 Jan 2019 

Jan 17 (Reuters) - Cerecor Inc ::CERECOR INC FILES FOR SECONDARY OFFERING OF UP TO 18.3 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

FDA Grants Cerecor's Three Substrate Replacement Therapies Orphan Drug Designation
Wednesday, 16 Jan 2019 

Jan 16 (Reuters) - Cerecor Inc ::FDA GRANTS CERECOR’S THREE SUBSTRATE REPLACEMENT THERAPIES ORPHAN DRUG DESIGNATION.  Full Article

Cerecor Q3 Revenue $4.1 Million Versus $25 Million
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Cerecor Inc ::CERECOR REPORTS THIRD QUARTER 2018 RESULTS.Q3 REVENUE $4.1 MILLION VERSUS $25 MILLION.SEES FY 2018 REVENUE $18 MILLION TO $20 MILLION.  Full Article

Cerecor To Acquire Ichorion Therapeutics
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Cerecor Inc ::CERECOR TO ACQUIRE ICHORION THERAPEUTICS.CERECOR INC - TERMS OF AGREEMENT INCLUDE ISSUANCE OF APPROXIMATELY 5,800,000 SHARES OF CERECOR COMMON STOCK AT CLOSING.CERECOR INC - TRANSACTION WORTH APPROXIMATELY $26.6 MILLION IN STOCK PLUS POTENTIAL MILESTONES.CERECOR - TERMS OF DEAL INCLUDE DEVELOPMENT MILESTONES WORTH UP TO ADDITIONAL $15 MILLION, PAYABLE EITHER IN CERECOR STOCK OR IN CASH.CERECOR INC - DEAL WAS UNANIMOUSLY APPROVED BY BOARD OF BOTH CERECOR AND ICHORION.CERECOR INC - THERE IS POTENTIAL FOR FIRST 505(B)(2) PROGRAM'S NDA TO BE SUBMITTED WITHIN CALENDAR YEAR 2020.CERECOR - PATRICK J. CRUTCHER, FORMER CHAIRMAN OF BOARD & PRESIDENT OF ICHORION WILL BE JOINING CERECOR LEADERSHIP TEAM.  Full Article

Cerecor Files Prospectus Relating To Resale Of Up To 1 Mln Shares Of Common Stock
Friday, 7 Sep 2018 

Sept 7 (Reuters) - Cerecor Inc ::CERECOR - FILES PROSPECTUS RELATING TO RESALE BY SELLING STOCKHOLDER FROM TIME TO TIME OF UP TO 1 MILLION SHARES OF COMMON STOCK.  Full Article

Cerecor Inc Says On Aug 17 Enters Into A Securities Purchase Agreement With Armistice Capital Master Fund Ltd
Monday, 20 Aug 2018 

Aug 20 (Reuters) - Cerecor Inc ::CERECOR INC - ON AUG 17, CO ENTERED INTO A SECURITIES PURCHASE AGREEMENT WITH ARMISTICE CAPITAL MASTER FUND LTD - SEC FILING.CERECOR INC - COMPANY SOLD 1 MILLION SHARES OF COMPANY'S COMMON STOCK, $0.001 PAR VALUE PER SHARE FOR A PURCHASE PRICE OF $3.91 PER SHARE.CERECOR INC - GROSS PROCEEDS OF SECURITIES PURCHASE AGREEMENT TOTAL $3.9 MILLION.  Full Article

Cerecor announces leadership changes
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cerecor Inc :Cerecor announces leadership changes.Cerecor Inc - ‍Interim Chief Executive Officer John Kaiser and Chief Medical Officer Dr. Ronald Marcus stepping down​.Cerecor Inc - ‍Appoints Randal O. Jones and Robert C. Moscato, Jr. to board of directors​.Cerecor Inc - ‍ Names Robert Moscato as president and Chief Operating Officer​.Cerecor Inc - ‍Mariam Morris will continue as Cerecor's chief financial officer​.  Full Article